| - GRCh37:
- Chr1:229567777
- GRCh38:
- Chr1:229432030
| ACTA1 | R258G | Congenital myopathy, Nemaline myopathy | Likely pathogenic (Dec 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:229567255
- GRCh38:
- Chr1:229431508
| ACTA1 | K375N | Nemaline myopathy | Likely pathogenic (Jun 9, 2009) | criteria provided, single submitter |
| - GRCh37:
- Chr1:229568632
- GRCh38:
- Chr1:229432885
| ACTA1 | | Nemaline myopathy | Uncertain significance (Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:229568314
- GRCh38:
- Chr1:229432567
| ACTA1 | G148V | Nemaline myopathy, Centronuclear myopathy | Likely pathogenic (Jul 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:229567590
- GRCh38:
- Chr1:229431843
| ACTA1 | D290N | Nemaline myopathy | Pathogenic (Jun 9, 2009) | criteria provided, single submitter |
| - GRCh37:
- Chr1:229568582
- GRCh38:
- Chr1:229432835
| ACTA1 | E59K | Nemaline myopathy, not provided | Conflicting interpretations of pathogenicity (Mar 27, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152447971
- GRCh38:
- Chr2:151591457
| NEB | | Nemaline myopathy | Likely pathogenic (Aug 7, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152547236
- GRCh38:
- Chr2:151690722
| NEB | | Nemaline myopathy | Likely pathogenic (Aug 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152410449
- GRCh38:
- Chr2:151553935
| LOC126806373, NEB | K4806*, K6507* | Nemaline myopathy | Likely pathogenic (Apr 4, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152566169
- GRCh38:
- Chr2:151709655
| NEB | | Nemaline myopathy | Likely pathogenic (Mar 6, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152548600
- GRCh38:
- Chr2:151692086
| NEB | C693* | Nemaline myopathy, Nemaline myopathy 2 | Conflicting interpretations of pathogenicity (Jan 25, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152482058-152482062
- GRCh38:
- Chr2:151625544-151625548
| NEB | I3237fs, I3480fs | Nemaline myopathy | Likely pathogenic (Nov 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152501090-152506689
| NEB | | Nemaline myopathy | Pathogenic (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152465191-152566169
| NEB | | Nemaline myopathy | Likely pathogenic (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152500623
- GRCh38:
- Chr2:151644109
| NEB | R2556fs | Nemaline myopathy | Likely pathogenic (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152348754-152348755
- GRCh38:
- Chr2:151492240-151492241
| NEB, RIF1 | F6449fs, F8305fs, F8340fs | Nemaline myopathy | Likely pathogenic (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152355833-152355834
- GRCh38:
- Chr2:151499319-151499320
| NEB, RIF1 | H8031fs, H8066fs | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152362698-152362701
- GRCh38:
- Chr2:151506184-151506187
| NEB, RIF1 | Q6175fs, Q7876fs, Q7911fs | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic/Likely pathogenic (Jan 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152394675-152394676
- GRCh38:
- Chr2:151538161-151538162
| NEB | K5291fs, K6992fs | Nemaline myopathy | Likely pathogenic (Jan 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152435851
- GRCh38:
- Chr2:151579337
| NEB | | Nemaline myopathy 2, Nemaline myopathy, not provided
| Conflicting interpretations of pathogenicity (Jul 27, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152417568
- GRCh38:
- Chr2:151561054
| NEB | E4685*, E6386* | Nemaline myopathy 2, Nemaline myopathy | Pathogenic/Likely pathogenic (Jul 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152420445
- GRCh38:
- Chr2:151563931
| NEB | | Arthrogryposis multiplex congenita 6, Nemaline myopathy 2, Nemaline myopathy 2, Nemaline myopathy | Likely pathogenic (Oct 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152563394
- GRCh38:
- Chr2:151706880
| NEB | | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic (Aug 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152534469-152534484
- GRCh38:
- Chr2:151677955-151677970
| NEB | N1158fs | Nemaline myopathy, not provided, Nemaline myopathy 2
| Pathogenic (Aug 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152393712
- GRCh38:
- Chr2:151537198
| NEB | I5346fs, I7047fs | Nemaline myopathy | Likely pathogenic (May 8, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152418702
- GRCh38:
- Chr2:151562188
| NEB | W4605*, W6306* | Nemaline myopathy | Likely pathogenic (Aug 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152373047
- GRCh38:
- Chr2:151516533
| RIF1, NEB | R5910*, R7646*, R7611* | Nemaline myopathy, not provided, Nemaline myopathy 2
| Pathogenic (Oct 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152423811-152423814
- GRCh38:
- Chr2:151567297-151567300
| NEB | V4308fs, V6009fs | not provided, Nemaline myopathy, Nemaline myopathy 2
| Pathogenic/Likely pathogenic (Oct 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152427010
- GRCh38:
- Chr2:151570496
| NEB | | Nemaline myopathy 2, Arthrogryposis multiplex congenita 6, not provided, Nemaline myopathy, Nemaline myopathy 2 | Pathogenic (Aug 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152348681
- GRCh38:
- Chr2:151492167
| RIF1, NEB | R6474*, R8365*, R8330* | Nemaline myopathy, Nemaline myopathy 2, Nemaline myopathy 2, Arthrogryposis multiplex congenita 6, not provided | Pathogenic (Jan 4, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152370195
- GRCh38:
- Chr2:151513681
| RIF1, NEB | R7714*, R6013*, R7749* | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic/Likely pathogenic (Aug 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152410341
- GRCh38:
- Chr2:151553827
| LOC126806373, NEB | | Nemaline myopathy 2, Nemaline myopathy | Likely pathogenic (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152348211
- GRCh38:
- Chr2:151491697
| RIF1, NEB | L8414*, L8379*, L6523* | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic (Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152353542-152353543
- GRCh38:
- Chr2:151497028-151497029
| NEB, RIF1 | L8102fs, L8137fs | not provided, Nemaline myopathy, Nemaline myopathy 2
| Pathogenic/Likely pathogenic (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152574018
- GRCh38:
- Chr2:151717504
| NEB | G245fs | Nemaline myopathy | Likely pathogenic (Aug 25, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152536232-152536238
- GRCh38:
- Chr2:151679718-151679724
| NEB | | Nemaline myopathy, Nemaline myopathy 2 | Likely pathogenic (Aug 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152384042
- GRCh38:
- Chr2:151527528
| NEB, RIF1 | R7300*, R5564*, R7265* | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic/Likely pathogenic (Nov 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152402425
- GRCh38:
- Chr2:151545911
| NEB | E6852*, E5151* | Nemaline myopathy, Nemaline myopathy 2, not provided
| Pathogenic/Likely pathogenic (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152381779
- GRCh38:
- Chr2:151525265
| NEB, RIF1 | Y7425*, Y5689*, Y7390* | Nemaline myopathy, Nemaline myopathy 2, Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 | Pathogenic/Likely pathogenic (Jan 25, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152552143
- GRCh38:
- Chr2:151695629
| NEB | D542fs | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152354169-152354170
- GRCh38:
- Chr2:151497655-151497656
| NEB, RIF1 | V8126fs, V8091fs | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic (Aug 23, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152397984
- GRCh38:
- Chr2:151541470
| NEB | R6887*, R5186* | not provided, Nemaline myopathy 2, Inborn genetic diseases, Nemaline myopathy | Pathogenic/Likely pathogenic (Aug 29, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152420137
- GRCh38:
- Chr2:151563623
| NEB | Q6226*, Q4525* | Nemaline myopathy 2, Nemaline myopathy 2, Arthrogryposis multiplex congenita 6, Nemaline myopathy | Pathogenic (Mar 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152397209
- GRCh38:
- Chr2:151540695
| NEB | | Nemaline myopathy 2, Nemaline myopathy | Likely pathogenic (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152376273
- GRCh38:
- Chr2:151519759
| NEB, RIF1 | R7532*, R7497*, R5796* | not provided, Nemaline myopathy 2, Nemaline myopathy
| Pathogenic/Likely pathogenic (May 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152531800
- GRCh38:
- Chr2:151675286
| NEB | | Nemaline myopathy, not provided, Nemaline myopathy 2
| Pathogenic/Likely pathogenic (Oct 12, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152402400
- GRCh38:
- Chr2:151545886
| NEB | | Nemaline myopathy, Nemaline myopathy 2 | Likely pathogenic (May 30, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152346885
- GRCh38:
- Chr2:151490371
| NEB, RIF1 | | Arthrogryposis multiplex congenita 6, Nemaline myopathy 2, Nemaline myopathy 2, Nemaline myopathy | Likely pathogenic (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152350704-152350705
- GRCh38:
- Chr2:151494190-151494191
| NEB, RIF1 | R6327fs, R8218fs, R8183fs | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic (Oct 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152507378
- GRCh38:
- Chr2:151650864
| NEB | R2313* | Nemaline myopathy, Nemaline myopathy 2, NEB-related condition
| Pathogenic/Likely pathogenic (Feb 27, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152536234
- GRCh38:
- Chr2:151679720
| NEB | | not provided, Nemaline myopathy, Nemaline myopathy 2
| Pathogenic/Likely pathogenic (Jun 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152586128
- GRCh38:
- Chr2:151729614
| NEB | | not provided, Nemaline myopathy, Nemaline myopathy 2
| Pathogenic (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152539175
- GRCh38:
- Chr2:151682661
| NEB | | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic (Oct 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152353491-152353492
- GRCh38:
- Chr2:151496977-151496978
| NEB, RIF1 | M8119fs, M8154fs | Nemaline myopathy 2, Nemaline myopathy | Pathogenic/Likely pathogenic (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152500641
- GRCh38:
- Chr2:151644127
| NEB | Y2549* | Nemaline myopathy 2, Nemaline myopathy | Pathogenic/Likely pathogenic (Nov 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152527706
- GRCh38:
- Chr2:151671192
| NEB | G1446V | Nemaline myopathy 2, Nemaline myopathy | Conflicting interpretations of pathogenicity (Aug 16, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152354803-152354804
- GRCh38:
- Chr2:151498289-151498290
| NEB, RIF1 | R8094fs, R8059fs | Nemaline myopathy, not provided, Nemaline myopathy 2
| Pathogenic/Likely pathogenic (Jul 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152487810
- GRCh38:
- Chr2:151631296
| NEB | I3156fs | Nemaline myopathy, not provided, Nemaline myopathy 2
| Pathogenic/Likely pathogenic (Mar 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152354788-152354789
- GRCh38:
- Chr2:151498274-151498275
| RIF1, NEB | E8100fs, E8065fs | Nemaline myopathy, not provided, Nemaline myopathy 2, See cases | Pathogenic (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152353506-152353509
- GRCh38:
- Chr2:151496992-151496995
| NEB, RIF1 | P8114fs, P8149fs | Arthrogryposis multiplex congenita 6, Nemaline myopathy 2, Nemaline myopathy 2, Nemaline myopathy | Pathogenic/Likely pathogenic (Apr 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152550884
- GRCh38:
- Chr2:151694370
| NEB | D617fs | Inborn genetic diseases, Nemaline myopathy | Pathogenic/Likely pathogenic (Jun 12, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152352822
- GRCh38:
- Chr2:151496308
| NEB, RIF1 | R8187*, R6296*, R8152* | Nemaline myopathy 2, Arthrogryposis multiplex congenita 6, Nemaline myopathy, Nemaline myopathy 2, not provided | Pathogenic/Likely pathogenic (Dec 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152355813
- GRCh38:
- Chr2:151499299
| NEB, RIF1 | S8073*, S8038* | Nemaline myopathy, not provided, Nemaline myopathy 2
| Pathogenic/Likely pathogenic (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152417726
- GRCh38:
- Chr2:151561212
| NEB | S6366I, S4665I | Nemaline myopathy, Nemaline myopathy 2 | Pathogenic (Aug 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152473895
- GRCh38:
- Chr2:151617381
| NEB | R3722*, R3479* | Nemaline myopathy 2, Arthrogryposis multiplex congenita 6, not provided, Nemaline myopathy | Pathogenic/Likely pathogenic (Sep 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152520103
- GRCh38:
- Chr2:151663589
| NEB | S1908fs | Nemaline myopathy, Nemaline myopathy 2, not provided
| Pathogenic/Likely pathogenic (Jul 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152346969
- GRCh38:
- Chr2:151490455
| NEB, RIF1 | G8440fs, G8405fs, G6549fs | Nemaline myopathy, Nemaline myopathy 2 | Conflicting interpretations of pathogenicity (Jan 10, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152354227-152354228
- GRCh38:
- Chr2:151497713-151497714
| RIF1, NEB | L8106fs, L8071fs | Nemaline myopathy, not provided, Nemaline myopathy 2
| Pathogenic (Jun 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152376170
- GRCh38:
- Chr2:151519656
| RIF1, NEB | | Nemaline myopathy 2, Nemaline myopathy, not provided
| Conflicting interpretations of pathogenicity (Feb 27, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152536234
- GRCh38:
- Chr2:151679720
| NEB | | not provided, Nemaline myopathy 2, Nemaline myopathy
| Pathogenic (Aug 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152346553
- GRCh38:
- Chr2:151490039
| NEB, RIF1 | R8481*, R6590*, R8446* | not provided, Nemaline myopathy, Nemaline myopathy 2
| Pathogenic (Sep 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152382474
- GRCh38:
- Chr2:151525960
| RIF1, NEB | D7422H, D7387H, D5686H | Nemaline myopathy 2, not provided | Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152471058
- GRCh38:
- Chr2:151614544
| NEB | I3535T, I3778T | Nemaline myopathy, Nemaline myopathy 2, not specified, not provided | Conflicting interpretations of pathogenicity (Nov 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152544805
- GRCh38:
- Chr2:151688291
| NEB | | not provided, Nemaline myopathy, Nemaline myopathy 2
| Pathogenic/Likely pathogenic (May 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152357937
- GRCh38:
- Chr2:151501423
| NEB, RIF1 | R8032*, R7997* | Nemaline myopathy 2, Muscular dystrophy, Progressive proximal muscle weakness, Limb pain, NEB-related condition, Nemaline myopathy, not provided, Nemaline myopathy 2, Arthrogryposis multiplex congenita 6
| Pathogenic/Likely pathogenic (Nov 10, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152530990
- GRCh38:
- Chr2:151674476
| NEB | | Nemaline myopathy 2, Nemaline myopathy, not provided
| Pathogenic/Likely pathogenic (May 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152506894
- GRCh38:
- Chr2:151650380
| NEB | | Nemaline myopathy 2, Nemaline myopathy | Pathogenic/Likely pathogenic (May 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:229569803-229569804
- GRCh38:
- Chr1:229434056-229434057
| ACTA1, LOC122152321 | | Familial restrictive cardiomyopathy, Nemaline myopathy, Congenital myopathy with fiber type disproportion
| Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:229567664-229567665
- GRCh38:
- Chr1:229431917-229431918
| ACTA1 | | Familial restrictive cardiomyopathy, Nemaline myopathy, Congenital myopathy with fiber type disproportion
| Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:229567662-229567663
- GRCh38:
- Chr1:229431915-229431916
| ACTA1 | | Familial restrictive cardiomyopathy, Nemaline myopathy, Congenital myopathy with fiber type disproportion, Actin accumulation myopathy | Conflicting interpretations of pathogenicity (Mar 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:229567660-229567661
- GRCh38:
- Chr1:229431913-229431914
| ACTA1 | | Familial restrictive cardiomyopathy, Nemaline myopathy, Congenital myopathy with fiber type disproportion, Actin accumulation myopathy | Conflicting interpretations of pathogenicity (Jun 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:154140024
- GRCh38:
- Chr1:154167548
| TPM3 | | not provided, Nemaline myopathy, Congenital myopathy with fiber type disproportion
| Benign/Likely benign (Sep 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:154139381
- GRCh38:
- Chr1:154166905
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154139165-154139166
- GRCh38:
- Chr1:154166689-154166690
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154139165-154139166
- GRCh38:
- Chr1:154166689-154166690
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154138283
- GRCh38:
- Chr1:154165807
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154138266
- GRCh38:
- Chr1:154165790
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154138228
- GRCh38:
- Chr1:154165752
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154138202
- GRCh38:
- Chr1:154165726
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154137848
- GRCh38:
- Chr1:154165372
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154137694
- GRCh38:
- Chr1:154165218
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154137629
- GRCh38:
- Chr1:154165153
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154137165
- GRCh38:
- Chr1:154164689
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154136656-154136657
- GRCh38:
- Chr1:154164180-154164181
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154136591
- GRCh38:
- Chr1:154164115
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154136210
- GRCh38:
- Chr1:154163734
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154136080
- GRCh38:
- Chr1:154163604
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154135835-154135839
- GRCh38:
- Chr1:154163359-154163363
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154135445
- GRCh38:
- Chr1:154162969
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:154135383-154135384
- GRCh38:
- Chr1:154162907-154162908
| TPM3 | | Nemaline myopathy, Congenital myopathy with fiber type disproportion | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |